We are thrilled to share the announcement today that Digistain® are 1 of 4 FINALISTS for the 2024 Nature Spin-off Prize
Over 150 innovative technologies were diligently evaluated by a panel of scientists so we are very proud that our novel approach to breast cancer diagnostics has been recognised by this prestigious award panel.
Digistain was a finalist for the 2024 Nature Spin-off Prize.
In our ongoing effort to bring accessible cancer diagnostics to the regions that need them most, we are proud to announce the official launch of
We are thrilled to share that Digistain was hand selected by an expert panel of judges from EIT Health, AstraZeneca Spain, SERMAS and Hospital 12
It was an honour to take part in the recent Physics Deep Tech Showcase at Institute of Physics, hosted in partnership with the Venture Capital
Supported by:
To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.